[HTML][HTML] Placental models for evaluation of nanocarriers as drug delivery systems for pregnancy associated disorders

L Fliedel, K Alhareth, N Mignet, T Fournier, K Andrieux - Biomedicines, 2022 - mdpi.com
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

[PDF][PDF] Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders. Biomedicines 2022, 10, 936

L Fliedel, K Alhareth, N Mignet, T Fournier, K Andrieux - 2022 - pdfs.semanticscholar.org
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders

L Fliedel, K Alhareth, N Mignet, T Fournier… - …, 2022 - u-paris.hal.science
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders

L Fliedel, K Alhareth, N Mignet, T Fournier, K Andrieux - 2022 - agris.fao.org
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders.

L Fliedel, K Alhareth, N Mignet, T Fournier… - …, 2022 - search.ebscohost.com
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders

L Fliedel, K Alhareth, N Mignet, T Fournier… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders

L Fliedel, K Alhareth, N Mignet, T Fournier, K Andrieux - Biomedicines, 2022 - hal.science
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders.

L Fliedel, K Alhareth, N Mignet, T Fournier… - Biomedicines, 2022 - europepmc.org
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

[HTML][HTML] Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders

L Fliedel, K Alhareth, N Mignet, T Fournier… - Biomedicines, 2022 - ncbi.nlm.nih.gov
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …

Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders

L Fliedel, K Alhareth, N Mignet, T Fournier… - …, 2022 - search.proquest.com
Pregnancy-associated disorders affect around 20% of pregnancies each year around the
world. The risk associated with pregnancy therapeutic management categorizes pregnant …